Endothelin receptor antagonists vs placebo
Mortality mean duration of study 30.2 weeks · pulmonary arterial hypertension
Endothelin receptor antagonists showed no clear difference in mortality mean duration of study 30.2 weeks compared with placebo (low certainty).
1 finding from 1 review
- Endothelin receptor antagonists for pulmonary arterial hypertension 2021 · Cochrane Headline outcomes onlyOR 0.78 [0.58, 1.07]12 studies · 2889 participantsLow